CD8+T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy

被引:104
作者
Huseni, Mahrukh A. [1 ]
Wang, Lifen [1 ]
Klementowicz, Joanna E. [1 ]
Yuen, Kobe [1 ]
Breart, Beatrice [1 ]
Orr, Christine [1 ]
Liu, Li-fen [1 ]
Li, Yijin [1 ]
Gupta, Vinita [1 ]
Li, Congfen [1 ]
Rishipathak, Deepali [1 ]
Peng, Jing [1 ]
Senbabaoglu, Yasin [1 ]
Modrusan, Zora [1 ]
Keerthivasan, Shilpa [1 ]
Madireddi, Shravan [1 ]
Chen, Ying-Jiun [1 ]
Fraser, Eleanor J. [1 ]
Leng, Ning [1 ]
Hamidi, Habib [1 ]
Koeppen, Hartmut [1 ]
Ziai, James [1 ]
Hashimoto, Kenji [1 ]
Fasso, Marcella [1 ]
Williams, Patrick [1 ]
McDermott, David F. [2 ]
Rosenberg, Jonathan E. [3 ]
Powles, Thomas [4 ]
Emens, Leisha A. [5 ]
Hegde, Priti S. [1 ]
Mellman, Ira [1 ]
Turley, Shannon J. [1 ]
Wilson, Mark S. [1 ]
Mariathasan, Sanjeev [1 ]
Molinero, Luciana [1 ]
Merchant, Mark [1 ]
West, Nathaniel R. [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, New York, NY 10065 USA
[4] Queen Mary Univ London, Barts Canc Inst, Barts Expt Canc Med Ctr, London EC1M 6BQ, England
[5] Univ Pittsburgh, Hillman Canc Ctr, Med Ctr, Pittsburgh, PA 15213 USA
关键词
CD8(+) T-CELLS; METASTATIC UROTHELIAL CARCINOMA; SUPPRESSOR-CELLS; PD-L1; BLOCKADE; DIFFERENTIATION; EFFECTOR; EXPRESSION; STAT3; BET; ATEZOLIZUMAB;
D O I
10.1016/j.xcrm.2022.100878
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although immune checkpoint inhibitors (ICIs) are established as effective cancer therapies, overcoming ther-apeutic resistance remains a critical challenge. Here we identify interleukin 6 (IL-6) as a correlate of poor response to atezolizumab (anti-PD-L1) in large clinical trials of advanced kidney, breast, and bladder can-cers. In pre-clinical models, combined blockade of PD-L1 and the IL-6 receptor (IL6R) causes synergistic regression of large established tumors and substantially improves anti-tumor CD8+ cytotoxic T lymphocyte (CTL) responses compared with anti-PD-L1 alone. Circulating CTLs from cancer patients with high plasma IL-6 display a repressed functional profile based on single-cell RNA sequencing, and IL-6-STAT3 signaling inhibits classical cytotoxic differentiation of CTLs in vitro. In tumor-bearing mice, CTL-specific IL6R defi-ciency is sufficient to improve anti-PD-L1 activity. Thus, based on both clinical and experimental evidence, agents targeting IL-6 signaling are plausible partners for combination with ICIs in cancer patients.
引用
收藏
页数:21
相关论文
共 73 条
[1]   Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs) [J].
Alfaro, Carlos ;
Teijeira, Alvaro ;
Onate, Carmen ;
Perez, Guiomar ;
Sanmamed, Miguel F. ;
Pilar Andueza, Maria ;
Alignani, Diego ;
Labiano, Sara ;
Azpilikueta, Arantza ;
Rodriguez-Paulete, Alfonso ;
Garasa, Saray ;
Fusco, Juan P. ;
Aznar, Angela ;
Inoges, Susana ;
De Pizzol, Maria ;
Allegretti, Marcello ;
Medina-Echeverz, Jose ;
Berraondo, Pedro ;
Perez-Gracia, Jose L. ;
Melero, Ignacio .
CLINICAL CANCER RESEARCH, 2016, 22 (15) :3924-3936
[2]   Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial [J].
Balar, Arjun V. ;
Galsky, Matthew D. ;
Rosenberg, Jonathan E. ;
Powles, Thomas ;
Petrylak, Daniel P. ;
Bellmunt, Joaquim ;
Loriot, Yohann ;
Necchi, Andrea ;
Hoffman-Censits, Jean ;
Perez-Gracia, Jose Luis ;
Dawson, Nancy A. ;
van der Heijden, Michiel S. ;
Dreicer, Robert ;
Srinivas, Sandy ;
Retz, Margitta M. ;
Joseph, Richard W. ;
Drakaki, Alexandra ;
Vaishampayan, Ulka N. ;
Sridhar, Srikala S. ;
Quinn, David I. ;
Duran, Ignacio ;
Shaffer, David R. ;
Eigl, Bernhard J. ;
Grivas, Petros D. ;
Yu, Evan Y. ;
Li, Shi ;
Kadel, Edward E., III ;
Boyd, Zachary ;
Bourgon, Richard ;
Hegde, Priti S. ;
Mariathasan, Sanjeev ;
Thastrom, AnnChristine ;
Abidoye, Oyewale O. ;
Fine, Gregg D. ;
Bajorin, Dean F. .
LANCET, 2017, 389 (10064) :67-76
[3]   Transcriptional insights into the CD8+ T cell response to infection and memory T cell formation [J].
Best, J. Adam ;
Blair, David A. ;
Knell, Jamie ;
Yang, Edward ;
Mayya, Viveka ;
Doedens, Andrew ;
Dustin, Michael L. ;
Goldrath, Ananda W. .
NATURE IMMUNOLOGY, 2013, 14 (04) :404-412
[4]   IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma [J].
Biffi, Giulia ;
Oni, Tobiloba E. ;
Spielman, Benjamin ;
Hao, Yuan ;
Elyada, Ela ;
Park, Youngkyu ;
Preall, Jonathan ;
Tuveson, David A. .
CANCER DISCOVERY, 2019, 9 (02) :282-301
[5]   Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling [J].
Brown, Flavian D. ;
Sen, Debattama R. ;
LaFleur, Martin W. ;
Godec, Jernej ;
Lukacs-Kornek, Veronika ;
Schildberg, Frank A. ;
Kim, Hye-Jung ;
Yates, Kathleen B. ;
Ricoult, Stephane J. H. ;
Bi, Kevin ;
Trombley, Justin D. ;
Kapoor, Varun N. ;
Stanley, Illana A. ;
Cremasco, Viviana ;
Danial, Nika N. ;
Manning, Brendan D. ;
Sharpe, Arlene H. ;
Haining, W. Nicholas ;
Turley, Shannon J. .
NATURE IMMUNOLOGY, 2019, 20 (12) :1668-+
[6]   A STAT3-dependent transcriptional circuitry inhibits cytotoxic gene expression in T cells [J].
Ciucci, Thomas ;
Vacchio, Melanie S. ;
Bosselut, Remy .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (50) :13236-13241
[7]   Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy [J].
Cristescu, Razvan ;
Mogg, Robin ;
Ayers, Mark ;
Albright, Andrew ;
Murphy, Erin ;
Yearley, Jennifer ;
Sher, Xinwei ;
Liu, Xiao Qiao ;
Lu, Hongchao ;
Nebozhyn, Michael ;
Zhang, Chunsheng ;
Lunceford, Jared ;
Joe, Andrew ;
Cheng, Jonathan ;
Webber, Andrea L. ;
Ibrahim, Nageatte ;
Plimack, Elizabeth R. ;
Ott, Patrick A. ;
Seiwert, Tanguy ;
Ribas, Antoni ;
McClanahan, Terrill K. ;
Tomassini, Joanne E. ;
Loboda, Andrey ;
Kaufman, David .
SCIENCE, 2018, 362 (6411) :197-+
[8]  
Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI [10.1093/nar/gkt1102, 10.1093/nar/gkz1031]
[9]   An Interleukin-21-Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells [J].
Cui, Weiguo ;
Liu, Ying ;
Weinstein, Jason S. ;
Craft, Joseph ;
Kaech, Susan M. .
IMMUNITY, 2011, 35 (05) :792-805
[10]   FOXO1 opposition of CD8+ T cell effector programming confers early memory properties and phenotypic diversity [J].
Delpoux, Arnaud ;
Lai, Chen-Yen ;
Hedrick, Stephen M. ;
Doedens, Andrew L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (42) :E8865-E8874